Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Borealis Ventures

Investor type Venture Capital
Founders Jesse Devitte Matt Harris Phil Ferneau


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Looking for a perfect list of funds?

Get recommendations from our smart algorithm

Get the list
Total investments 53
Average round size
The average size of a deal this fund participated in
Portfolio companies 33
Rounds per year 2.65
Lead investments 10
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 9
Key employees 4
Stages of investment
Early Stage Venture
Late Stage Venture
Private Equity

Areas of investment

  • Software
  • Biotechnology
  • Health Care
  • Enterprise Software
  • Construction

The venture was found in North America in United States. The main department of described VC is located in the Hanover.

Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline Helix, Vets First Choice, Flurry For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular fund investment industries, there are Construction, Information Technology. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 4 or 5+ of the founder, the chance for it to get the investment is meager.

The fund was created by Jesse Devitte, Matt Harris, Phil Ferneau. Besides them, we counted 4 critical employees of this fund in our database.

The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the Borealis Ventures, startups are often financed by North Bridge Venture Partners & Growth Equity, Kodiak Venture Partners, SV Health Investors. The meaningful sponsors for the fund in investment in the same round are North Bridge Venture Partners & Growth Equity, Kodiak Venture Partners, Village Ventures. In the next rounds fund is usually obtained by Building Ventures, North Bridge Venture Partners & Growth Equity, Kodiak Venture Partners.

Comparing to the other companies, this Borealis Ventures performs on 11 percentage points less the average number of lead investments. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2017. The usual things for fund are deals in the range of 5 - 10 millions dollars. The typical startup value when the investment from Borealis Ventures is 10-50 millions dollars. The high activity for fund was in 2018. Despite it in 2019 the fund had an activity. Speaking about the real fund results, this VC is 0 percentage points less often commits exit comparing to other organizations.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Borealis Ventures:
Typical Co-investors
Borealis Ventures is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Borealis Ventures:

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Alerion Partners Connecticut, Darien, United States
CalCEF Clean Energy Angel Fund California, San Francisco, United States
Coconut Tree Investments -
DLJDirect England, Leeds, United Kingdom Copenhagen, Denmark, Hovedstaden
Great Pacific Securities -
Jiaxing Canshi Lukejiuhao Touzi Guanli Hehuo Qiye (Limited Partnership) China, Jiaxing, Zhejiang
Liberty Financial Companies, Inc Boston, Massachusetts, United States
Life Sciences Alternative Funding New York, United States, White Plains
Mezzetti Advisory Group. Italy, Lombardy, Milan
Mix Labs -
NextTech Group of Technopreneurs Hanoi, Vietnam
Schurz Communications Indiana, Mishawaka, United States
Seven Tree Equity Partners -
Shangcap Partners -
Shenzhen Xiaoxi Holdings -
Solidity Ventures -
Tameny Japan, Tokyo
Whittier Ventures Boston, Massachusetts, United States
Zhongjing Ruiyi Beijing, China, Pinggu

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation


$45M12 Nov 2021 Boston, Massachusetts, United States

Orbit Discovery

Health Care
$7M20 Jul 2021 Oxford, England, United Kingdom


Enterprise Software
Life Science
$21M16 Dec 2020 Cambridge, Massachusetts, United States


Health Care
Information Technology
$10M29 Oct 2020 Palo Alto, California, United States


Enterprise Software
Life Science
$5M14 Mar 2019 Cambridge, Massachusetts, United States


Information Services
Information Technology
Life Science
$25M14 Feb 2019 New York, New York, United States

Evox Therapeutics

Health Care
$47M02 Sep 2018 Oxford, England, United Kingdom

Compass Therapeutics

$49M12 Jul 2018 Boston, Massachusetts, United States

Orbit Discovery

Health Care
$9M23 May 2018 Oxford, England, United Kingdom
Orbit Discovery Announces $7.6 Million Funding to Accelerate Growth in Peptide Discovery Business

– Orbit Discovery has raised $7.6m in funding.
– The financing was led by Oxford Sciences Innovation with participation from Borealis Ventures, Perivoli Innovations, and other institutional and individual investors, including Kapil Dev Joory.
– Proceeds from the financing will be used to accelerate Orbit’s growth trajectory as a leading provider of peptide discovery services to the biotechnology and pharmaceutical industry.
– Orbit’s novel bead-based and microfluidic technology platform enables the screening of peptide libraries for target binding and subsequent activity in cell-based functional assays.
– This makes the platform ideal for identifying active peptides against both soluble proteins and membrane bound targets such as GPCRs.
– Until now, researchers have struggled to unite high throughput affinity screens with functional screens utilising peptide libraries of very high chemical diversity.


  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Borealis Ventures?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: